Literature DB >> 7080013

Effect of pH on bronchial response to inhaled histamine.

D W Cockcroft, B A Berscheid.   

Abstract

In order to investigate the effect of pH on bronchial responsiveness to inhaled histamine, 15 subjects with non-specific bronchial hyperreactivity performed two histamine inhalation tests, one with unbuffered, and the other with buffered histamine acid phosphate solutions. The unbuffered histamine solutions were prepared with 0.9% sterile saline and had a pH range from 4.3 to 7.3, while the buffered histamine solutions were prepared with a phosphate buffer and had a pH range of 6.5 to 7.4. The two histamine inhalation tests were similar in all other regards. The geometric mean histamine provocation concentration required to produce a 20% reduction in FEV1 (PC20) was significantly lower for the unbuffered histamine (1.33 mg/ml) than for the buffered histamine (1.67 mg/ml), p less than 0.05. The two PC20s differed by less than one doubling dilution, the range of reproducibility of the test, in 12 of the 15 subjects. The pH effect was only noted when the pH of the histamine solutions was below five (histamine concentrations from one to eight mg/ml). We conclude that the acid pH of higher concentrations of histamine acid phosphate solutions has a slight but significant enhancing effect on the bronchial responsiveness to inhaled histamine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7080013      PMCID: PMC459264          DOI: 10.1136/thx.37.2.133

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  14 in total

1.  Standardization of bronchial inhalation challenge procedures.

Authors:  H Chai; R S Farr; L A Froehlich; D A Mathison; J A McLean; R R Rosenthal; A L Sheffer; S L Spector; R G Townley
Journal:  J Allergy Clin Immunol       Date:  1975-10       Impact factor: 10.793

2.  Protective effect of drugs on histamine-induced asthma.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Thorax       Date:  1977-08       Impact factor: 9.139

3.  Bronchial reactivity to inhaled histamine: a method and clinical survey.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Clin Allergy       Date:  1977-05

4.  Histamine and metacholine challenge in the testing of bronchial reactivity.

Authors:  L A Laitinen
Journal:  Scand J Respir Dis Suppl       Date:  1974

5.  Provocation of bronchial obstruction in bronchial asthma by dilute histamine aerosols.

Authors:  H Herxheimer
Journal:  Acta Allergol       Date:  1972

6.  Allergen-induced increase in non-allergic bronchial reactivity.

Authors:  D W Cockcroft; R E Ruffin; J Dolovich; F E Hargreave
Journal:  Clin Allergy       Date:  1977-11

Review 7.  [Non-specific bronchial provocation tests in asthma (author's transl)].

Authors:  J Orehek; P Gayrard
Journal:  Bull Eur Physiopathol Respir       Date:  1976 Jul-Aug

8.  Reproducibility and comparison of responses to inhaled histamine and methacholine.

Authors:  E F Juniper; P A Frith; C Dunnett; D W Cockcroft; F E Hargreave
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

9.  Further studies on the mechanism of human histamine-induced asthma: the effect of an aerosolized H1 receptor antagonist (diphenhydramine).

Authors:  C L Casterline; R Evans
Journal:  J Allergy Clin Immunol       Date:  1977-06       Impact factor: 10.793

10.  Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection.

Authors:  D W Empey; L A Laitinen; L Jacobs; W M Gold; J A Nadel
Journal:  Am Rev Respir Dis       Date:  1976-02
View more
  3 in total

Review 1.  Bronchial challenges.

Authors:  H Chai
Journal:  Clin Rev Allergy       Date:  1988

2.  Adverse reactions to the non-drug constituents of nebuliser solutions.

Authors:  R Beasley; P Rafferty; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

3.  The contribution of histamine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma.

Authors:  K A Miszkiel; R Beasley; P Rafferty; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.